Medium materiality5/10
UBS raises Molina Healthcare price target to $225
Why it may matterVerify against the original reporting
The higher target is a modest positive signal; the limited gap to the posted price tempers its significance.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raised its MOH target from $202 to $225, roughly 4% above the posted price of $216.64. The meaningful upward revision is bullish, but implied upside at the posted price is limited.
- Target raised from $202 to $225.
- New target is roughly 4% above the posted price.
Key facts
- 01
Target: $225
- 02
Posted price: $216.64
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.